Trials / Conditions / Steroid Refractory Graft Versus Host Disease
Steroid Refractory Graft Versus Host Disease
5 registered clinical trials studyying Steroid Refractory Graft Versus Host Disease — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With NCT05993611 | City of Hope Medical Center | Phase 1 |
| Terminated | Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD NCT04910152 | Hannah Choe, MD | Phase 1 / Phase 2 |
| Recruiting | Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Re NCT04744116 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Active Not Recruiting | Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease NCT04212416 | City of Hope Medical Center | Phase 1 |
| Terminated | Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD) NCT01903473 | University of Liege | Phase 2 |